Designated presentation

[SY6] Symposium: Newly-occurring signaling pathway ameliorating rare and refractory diseases

Thu. Sep 10, 2020 5:50 PM - 7:30 PM A (Zoom A)

Chair person:Junji Yamauchi(Tokyo University of Pharmacy and Life Sciences), Norio Takagi(Tokyo University of Pharmacy and Life Sciences)

+Add all to schedule

[SY6] Live会場はこちら（Zoom）

5:50 PM - 6:10 PM

[SY6-01] Cell Adhesion Proteins Regulate Myelination of Small Caliber Axons Critically Involved in Myelin-related Diseases

*Nobuharu Suzuki¹ (1. Dept. of Mol. and Cell. Biol., Grad. Sch. of Med. and Dent. Sci., Tokyo Medical and Dental University)

6:10 PM - 6:30 PM

[SY6-02] New molecular pathways to improve the expanding Pelizaeus– Merzbacher disease

*Junji Yamauchi^1,2, Yuki Miyamoto^1,2 (1. TUPLS, 2. NICHD)

6:30 PM - 6:50 PM

[SY6-03] Transcriptional Regulation by Cereblon, a Gene Product Responsible for Intellectual Disability

*Naoya Sawamura^1,2 (1. Research Organization for Nano & Life Innovation, Waseda University, 2. Green Computing Systems Research Organization, Waseda University)

6:50 PM - 7:10 PM

[SY6-04] Protection against optic nerve degeneration by low density lipoprotein receptor-related protein 1 signaling

*Hideki Hayashi¹, Norio Takagi¹ (1. Tokyo University of Pharmacy and Life Sciences)

7:10 PM - 7:30 PM

[SY6-05] Therapeutic effects of Rubicon knockdown in a Drosophila model of polyglutamine disease.

*Mari Suzuki¹ (1. Tokyo Metropolitan Institute of Medical Science)

Session information